The acquired portfolio consists of 13 ANDAs already approved by the Food and Drug Administration and one pending approval.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback